ID   ORIONi002-A
AC   CVCL_C1QB
SY   iALS-2
DR   BioSamples; SAMEA12999351
DR   hPSCreg; ORIONi002-A
DR   Wikidata; Q114312638
RX   PubMed=35907349;
CC   From: Biomedical Center Martin, Jessenius Faculty of Medicine, Comenius University; Martin; Slovakia.
CC   Population: Caucasian.
CC   Derived from site: In situ; Leg, skin; UBERON=UBERON_0001511.
CC   Cell type: Fibroblast of skin; CL=CL_0002620.
ST   Source(s): PubMed=35907349
ST   Amelogenin: X,Y
ST   CSF1PO: 10
ST   D13S317: 8,11
ST   D16S539: 11,13
ST   D5S818: 12
ST   D7S820: 10,12
ST   TH01: 8,9.3
ST   TPOX: 8,10
ST   vWA: 15,17
DI   NCIt; C34373; Amyotrophic lateral sclerosis
DI   ORDO; Orphanet_803; Amyotrophic lateral sclerosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   45Y
CA   Induced pluripotent stem cell
DT   Created: 22-09-22; Last updated: 29-06-23; Version: 4
//
RX   PubMed=35907349; DOI=10.1016/j.scr.2022.102870;
RA   Strnadel J., Dumortier H.M., Hajduchova D., Zahumenska R., Nosal V.,
RA   Smolar M., Marcinek J., Kalman M., Mersakova S., Brany D., Juhas S.,
RA   Juhasova J., Studenovska H., Mitruskova B., Suroviakova S.,
RA   Novakova S., Skovierova H., Kurca E., Pecova R., Plank L.,
RA   Halasova E.;
RT   "In vitro modeling of amyotrophic lateral sclerosis with induced
RT   pluripotent stem cell technology-derived cell line ORIONi002-A.";
RL   Stem Cell Res. 63:102870-102870(2022).
//